Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 72205-054

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 72205-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fosaprepitant-carton-label (Fosaprepitant Carton Label)

Fosaprepitant-carton-label (Fosaprepitant Carton Label)
The text provides details about a pharmaceutical product with GTIN, SN, EXP, & LOT codes that need to be over-coded with 2D during packing. The product is fosaprepitant and comes in single-dose vials which should be discarded if unused. The package should be kept in an unvarnished area for cading and reconstituted with 5L of 0% Sodium Chloride for injection. The manufacturer of this product is Fosaprptan by MSN Laboratories Private Limited and is available only by prescription.*
FDA Label Image

Str (Fosaprepitant Structure)

FDA Label Image

Fosaprepitant-vial-label (Fosaprepitant Vial Label)

Fosaprepitant-vial-label (Fosaprepitant Vial Label)
NDC 7220 5_0 5 4_01 is a sterile lyophilized powder for intravenous injection. It comes in a single-dose vial and has 150 mg per vial. Store the vial refrigerated at 2°C to 8°C (36°F to 46°F) and use it only after reconstitution and dilution. The reconstituted final drug solution is stable for 24 hours at ambient room temperature. Usual Dosage: See Prescribing information. Manufactured by MSN Laboratories Private Limited and distributed by Novadoz Pharmaceuticals LLC. For unused portions of the drug, discard the single-dose vial. Contact Novadoz Pharmaceuticals LLC at 855-NOVADOZ for any further information. The issue date of this product is 02/2020.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.